Skip to main content
Article
Alliance for clinical trials in oncology (ALLIANCE) trial A021501: Preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas
BMC Cancer (2017)
  • Matthew H. G. Katz, University of Texas MD Anderson Cancer Center
  • Fang-Shu Ou, Mayo Clinic
  • Joseph M. Herman, University of Texas MD Anderson Cancer Center
  • Syed A. Ahmad, University of Cincinnati
  • Brian Wolpin, Harvard University
  • Robert Marsh, NorthShore University HealthSystem
  • Spencer Behr, University of California, San Francisco
  • Qian Shi, Mayo Clinic
  • Michael Chuong, University of Maryland Marlene and Stewart Greenebaum Cancer Center
  • Lawrence H. Schwartz, NewYork–Presbyterian Hospital
  • Wendy Frankel, Ohio State University
  • Eric Collisson, University of California, San Francisco
  • Eugene J. Koay, University of Texas MD Anderson Cancer Center
  • JoLeen M. Hubbard, Mayo Clinic
  • James L. Leenstra, Mayo Clinic
  • Jeffrey Meyerhardt, Harvard University
  • Eileen O’Reilly, Memorial Sloan Kettering Cancer Center
Publication Date
January 12, 2017
DOI
10.1186/s12885-017-3441-z
Citation Information
Matthew H. G. Katz, Fang-Shu Ou, Joseph M. Herman, Syed A. Ahmad, et al.. "Alliance for clinical trials in oncology (ALLIANCE) trial A021501: Preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas" BMC Cancer Vol. 17 Iss. 1 (2017) p. 505
Available at: http://works.bepress.com/michael-chuong/2/